Biogen Idec (NQ: BIIB )
231.82
+3.10
(+1.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Headline News about Biogen Idec![]() ![]()
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Via Benzinga
![]() ![]()
1 Green Flag and 1 Red Flag for Biogen
December 23, 2022
Via The Motley Fool
![]() ![]() ![]()
26 Analysts Have This to Say About Biogen
November 30, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
CBOE's Weekly Market Recap: Nov.14-18 – Biogen’s Alzheimer’s Drug Captures Investors’ Attention
November 23, 2022
Via News Direct
Exposures
Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|